Skip to main content

EBS Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Emergent Biosolutions Inc. News

Emergent BioSolutions Begins Phase 1 Trial for Universal Flu Vaccine

Emergent says its flu-vaccine candidate 'contains multiple components to induce broad, supra-seasonal immunity against influenza A viruses.'

FDA Reveals Details of Problems at Third-Party Maker of JNJ Shot

'Cross contamination' issues found at Emergent BioSolution's Maryland facility, according to memo.

Cramer's Mad Money Recap: AT&T, Time Warner and Discovery

Jim Cramer says there are some lessons to be learned from the AT&T-Time Warner deal, and some better deals investors should consider.

Johnson & Johnson Shot's Benefits Outweigh Risks: Dr. Collins

Chance of getting clots from vaccine called less likely than getting 'struck by lightning.'

Committee Advises J&J Vaccine Use Be Resumed

FDA and CDC told that use of the J&J vaccine should be resumed as benefits outweigh risks.

Breaking News

Fed Inflation Gauge Eases Again In May, But Inflation Pressures Clip Consumer Spending

While overall inflation pressures are easing modestly, the impact of the fastest inflation in four decades is taking its toll on spending, BEA data indicated Thursday.

Pfizer Stock Jumps On $3.2 Billion U.S. Covid Vaccine Sale, FDA Paxlovid Approval Filing

“As the Covid pandemic continues to evolve and be highly unpredictable, we must remain vigilant in protecting those who are at greatest risk of getting very sick from Covid," said CEO Albert Bourla.

Walgreens Stock Slides After Q3 Profit Beat, $683 Million Florida Opioid Charge

"WBA delivered strong execution across operating segments and against very robust growth last year," said CEO Rosalind Brewer.

Micron Earnings Preview: Will Critical Support Hold?

Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?